Anavex Life Sciences Corp. (AVXL) NASDAQ
2.80
-0.18(-6.04%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.80
-0.18(-6.04%)
Currency In USD
| Market Cap | 759.08M |
| Enterprise Value | 656.5M |
| P/E Ratio | -6.24 |
| PEG Ratio | -0.38 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.97 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.19 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.3 |
| Return On Equity | -0.39 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -46.38M |
| Net Income | -46.38M |
| Diluted EPS | -0.54 |
| Total Cash | 131.75M |
| Total Cash/Share | 1.48 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 20.87 |
| Book Value Per Share | 1.42 |
| 52-Week Change | -62.96 |
| 52-Week High | 13.99 |
| 52-Week Low | 2.61 |
| Moving Average 50 Days | 3.17 |
| Moving Average 200 Days | 5.46 |
| Average Volume | 1.37M |
| Shares Outstanding | 92.67M |
| % Held by Institutions | 44.51 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | October 07, 2015 |